Principal Financial Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-588
Closed -$323K 2522
2022
Q1
$323K Buy
588
+38
+7% +$23K ﹤0.01% 2219
2021
Q4
$364K Sell
550
-121
-18% -$92.5K ﹤0.01% 2199
2021
Q3
$563K Buy
671
+160
+31% +$162K ﹤0.01% 2145
2021
Q2
$649K Sell
511
-8,933
-95% -$10.1M ﹤0.01% 2148
2021
Q1
$10.4M Buy
+9,444
New +$12.5M 0.01% 1370

Other funds holding CDLX

Principal Financial Group's CDLX Position: Q2 2022 in Review

Principal Financial Group sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 588 shares — an estimated $323K sold.

Principal Financial Group first reported a position in CDLX in Q1 2021 and held it in 5 quarters. The position peaked at $10.4M in Q1 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • Principal Financial Group reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 588 Cardlytics shares in Q2 2022, an estimated $323K.
  • Principal Financial Group first reported a position in Cardlytics in Q1 2021 and held it in 5 quarters.
  • Principal Financial Group's Cardlytics position peaked at $10.4M in Q1 2021.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.